| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |